The increasing role of the allergist in the management of infusion reactions at the Oncology Infusion Center

BackgroundHypersensitivity reactions to chemotherapy disrupt treatment schedules and compromise patient outcomes. Rapid Drug Desensitization (RDD) enables patients to tolerate future treatments after an allergy workup. However, Same-Day Desensitization (SDD) is a novel approach that capitalizes on R...

Full description

Saved in:
Bibliographic Details
Main Authors: Julián Borrás Cuartero, Maria Cruz Torres Górriz, Cristina Isabel Stein Coronado, Adrián Germán Sánchez, Cristina Giovanna Pesántez Méndez, Maria Dolores Latorre Ibáñez, Ernesto Enrique
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Allergy
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/falgy.2024.1479469/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846128042309582848
author Julián Borrás Cuartero
Maria Cruz Torres Górriz
Maria Cruz Torres Górriz
Maria Cruz Torres Górriz
Cristina Isabel Stein Coronado
Cristina Isabel Stein Coronado
Adrián Germán Sánchez
Adrián Germán Sánchez
Cristina Giovanna Pesántez Méndez
Cristina Giovanna Pesántez Méndez
Maria Dolores Latorre Ibáñez
Ernesto Enrique
Ernesto Enrique
Ernesto Enrique
author_facet Julián Borrás Cuartero
Maria Cruz Torres Górriz
Maria Cruz Torres Górriz
Maria Cruz Torres Górriz
Cristina Isabel Stein Coronado
Cristina Isabel Stein Coronado
Adrián Germán Sánchez
Adrián Germán Sánchez
Cristina Giovanna Pesántez Méndez
Cristina Giovanna Pesántez Méndez
Maria Dolores Latorre Ibáñez
Ernesto Enrique
Ernesto Enrique
Ernesto Enrique
author_sort Julián Borrás Cuartero
collection DOAJ
description BackgroundHypersensitivity reactions to chemotherapy disrupt treatment schedules and compromise patient outcomes. Rapid Drug Desensitization (RDD) enables patients to tolerate future treatments after an allergy workup. However, Same-Day Desensitization (SDD) is a novel approach that capitalizes on RDD to allow the continuation of chemotherapy on the same day as the index reaction, preventing treatment delays.ObjectiveTo evaluate the safety and efficacy of SDD in managing hypersensitivity reactions during chemotherapy and emphasize the essential role of allergists in the Oncology Infusion Center (OIC) for accurate drugs hypersensitivity reactions (DHRs) phenotyping and management.MethodsThis retrospective cohort included patients experiencing DHRs during chemotherapy. Under allergist supervision, SDD was performed once the index reaction was controlled. At a later date, clinical phenotypes and endotypes of DHRs were assessed through clinical history, skin tests, serum biomarkers (including tryptase and IL-6 levels), and drug provocation testing (DPT) to reach an accurate diagnosis.ResultsSDD was successful in 35 cases, even for patients with severe initial reactions. Only 14% experienced breakthrough reactions, all mild. Same-day assessment by allergists ensured a 92% correlation between initial and final diagnoses, optimizing DHR management. Early engagement with Allergy allowed 86% of reactive patients to continue treatment through RDD or after ruling out an allergy.ConclusionSDD is a safe and effective procedure that ensures that patients don't miss their oncology treatment on the day of a reaction. The presence of an allergist in the OIC is crucial for rapid access to accurate DHR phenotyping and optimal management, supporting personalized precision medicine in oncology.
format Article
id doaj-art-809b50aac03f46edbf2b76f6d5aab4ab
institution Kabale University
issn 2673-6101
language English
publishDate 2024-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Allergy
spelling doaj-art-809b50aac03f46edbf2b76f6d5aab4ab2024-12-11T06:44:35ZengFrontiers Media S.A.Frontiers in Allergy2673-61012024-12-01510.3389/falgy.2024.14794691479469The increasing role of the allergist in the management of infusion reactions at the Oncology Infusion CenterJulián Borrás Cuartero0Maria Cruz Torres Górriz1Maria Cruz Torres Górriz2Maria Cruz Torres Górriz3Cristina Isabel Stein Coronado4Cristina Isabel Stein Coronado5Adrián Germán Sánchez6Adrián Germán Sánchez7Cristina Giovanna Pesántez Méndez8Cristina Giovanna Pesántez Méndez9Maria Dolores Latorre Ibáñez10Ernesto Enrique11Ernesto Enrique12Ernesto Enrique13Allergy Department, Castellon Provincial Hospital Consortium, Castellon de la Plana, SpainAllergy Department, Castellon University General Hospital, Castellon de la Plana, SpainDoctoral School, Jaume I University, Castellon de la Plana, SpainFISABIO Foundation Research Group, Valencia, SpainAllergy Department, Castellon University General Hospital, Castellon de la Plana, SpainFISABIO Foundation Research Group, Valencia, SpainAllergy Department, Castellon University General Hospital, Castellon de la Plana, SpainFISABIO Foundation Research Group, Valencia, SpainAllergy Department, Castellon University General Hospital, Castellon de la Plana, SpainFISABIO Foundation Research Group, Valencia, SpainRIA Laboratory Service - Radiopharmacy, Castellon Provincial Hospital Consortium, Castellon de la Plana, SpainAllergy Department, Castellon University General Hospital, Castellon de la Plana, SpainDoctoral School, Jaume I University, Castellon de la Plana, SpainFISABIO Foundation Research Group, Valencia, SpainBackgroundHypersensitivity reactions to chemotherapy disrupt treatment schedules and compromise patient outcomes. Rapid Drug Desensitization (RDD) enables patients to tolerate future treatments after an allergy workup. However, Same-Day Desensitization (SDD) is a novel approach that capitalizes on RDD to allow the continuation of chemotherapy on the same day as the index reaction, preventing treatment delays.ObjectiveTo evaluate the safety and efficacy of SDD in managing hypersensitivity reactions during chemotherapy and emphasize the essential role of allergists in the Oncology Infusion Center (OIC) for accurate drugs hypersensitivity reactions (DHRs) phenotyping and management.MethodsThis retrospective cohort included patients experiencing DHRs during chemotherapy. Under allergist supervision, SDD was performed once the index reaction was controlled. At a later date, clinical phenotypes and endotypes of DHRs were assessed through clinical history, skin tests, serum biomarkers (including tryptase and IL-6 levels), and drug provocation testing (DPT) to reach an accurate diagnosis.ResultsSDD was successful in 35 cases, even for patients with severe initial reactions. Only 14% experienced breakthrough reactions, all mild. Same-day assessment by allergists ensured a 92% correlation between initial and final diagnoses, optimizing DHR management. Early engagement with Allergy allowed 86% of reactive patients to continue treatment through RDD or after ruling out an allergy.ConclusionSDD is a safe and effective procedure that ensures that patients don't miss their oncology treatment on the day of a reaction. The presence of an allergist in the OIC is crucial for rapid access to accurate DHR phenotyping and optimal management, supporting personalized precision medicine in oncology.https://www.frontiersin.org/articles/10.3389/falgy.2024.1479469/fulldrug allergyRapid Drug DesensitizationSame-Day Desensitizationchemotherapy allergypersonalized and precision medicine
spellingShingle Julián Borrás Cuartero
Maria Cruz Torres Górriz
Maria Cruz Torres Górriz
Maria Cruz Torres Górriz
Cristina Isabel Stein Coronado
Cristina Isabel Stein Coronado
Adrián Germán Sánchez
Adrián Germán Sánchez
Cristina Giovanna Pesántez Méndez
Cristina Giovanna Pesántez Méndez
Maria Dolores Latorre Ibáñez
Ernesto Enrique
Ernesto Enrique
Ernesto Enrique
The increasing role of the allergist in the management of infusion reactions at the Oncology Infusion Center
Frontiers in Allergy
drug allergy
Rapid Drug Desensitization
Same-Day Desensitization
chemotherapy allergy
personalized and precision medicine
title The increasing role of the allergist in the management of infusion reactions at the Oncology Infusion Center
title_full The increasing role of the allergist in the management of infusion reactions at the Oncology Infusion Center
title_fullStr The increasing role of the allergist in the management of infusion reactions at the Oncology Infusion Center
title_full_unstemmed The increasing role of the allergist in the management of infusion reactions at the Oncology Infusion Center
title_short The increasing role of the allergist in the management of infusion reactions at the Oncology Infusion Center
title_sort increasing role of the allergist in the management of infusion reactions at the oncology infusion center
topic drug allergy
Rapid Drug Desensitization
Same-Day Desensitization
chemotherapy allergy
personalized and precision medicine
url https://www.frontiersin.org/articles/10.3389/falgy.2024.1479469/full
work_keys_str_mv AT julianborrascuartero theincreasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT mariacruztorresgorriz theincreasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT mariacruztorresgorriz theincreasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT mariacruztorresgorriz theincreasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT cristinaisabelsteincoronado theincreasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT cristinaisabelsteincoronado theincreasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT adriangermansanchez theincreasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT adriangermansanchez theincreasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT cristinagiovannapesantezmendez theincreasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT cristinagiovannapesantezmendez theincreasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT mariadoloreslatorreibanez theincreasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT ernestoenrique theincreasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT ernestoenrique theincreasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT ernestoenrique theincreasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT julianborrascuartero increasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT mariacruztorresgorriz increasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT mariacruztorresgorriz increasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT mariacruztorresgorriz increasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT cristinaisabelsteincoronado increasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT cristinaisabelsteincoronado increasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT adriangermansanchez increasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT adriangermansanchez increasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT cristinagiovannapesantezmendez increasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT cristinagiovannapesantezmendez increasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT mariadoloreslatorreibanez increasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT ernestoenrique increasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT ernestoenrique increasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter
AT ernestoenrique increasingroleoftheallergistinthemanagementofinfusionreactionsattheoncologyinfusioncenter